Literature DB >> 15962220

Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons.

Jason T Blackard1, Laura Smeaton, Yoichi Hiasa, Norio Horiike, Morikazu Onji, Denise J Jamieson, Irma Rodriguez, Kenneth H Mayer, Raymond T Chung.   

Abstract

It has been speculated that hepatitis C virus (HCV) replicates in peripheral-blood mononuclear cells (PBMCs), which, therefore, may be a site for interaction with human immunodeficiency virus (HIV). We used strand-specific real-time polymerase chain reaction to detect HCV RNA in 28 HCV-monoinfected and 20 HIV/HCV-coinfected women. At the first visit, positive-strand HCV RNA was detected in serum samples from 89% of the women, whereas positive-strand HCV RNA was detected in PBMC samples from 32% and 55% of the HCV-monoinfected and HIV/HCV-coinfected women, respectively. After initiation of antiretroviral therapy, the HIV/HCV-coinfected women were significantly more likely to have detectable positive- and negative-strand HCV RNA in the PBMC compartment than were the HCV-monoinfected women. HIV and HCV RNA levels were not correlated. Serum HCV RNA levels were correlated over time; HCV RNA levels in the serum and PBMC compartments were not. These data suggest differential regulation of HCV RNA in the serum and PBMC compartments and may partially explain the limited HCV antiviral response rates observed in coinfected persons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962220     DOI: 10.1086/430949

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients.

Authors:  S K Ippagunta; S Naik; S Jameel; K N S Ramana; R Aggarwal
Journal:  J Viral Hepat       Date:  2010-07-26       Impact factor: 3.728

2.  Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré.

Authors:  Patricia Baré
Journal:  World J Hepatol       Date:  2009-10-31

3.  Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women.

Authors:  Tomasz Laskus; Eva A Operskalski; Marek Radkowski; Jeffrey Wilkinson; Wendy J Mack; Marina deGiacomo; Lena Al-Harthi; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  J Infect Dis       Date:  2006-11-27       Impact factor: 5.226

Review 4.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

5.  Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells.

Authors:  Hua Liang; Rodney S Russell; Nicole L Yonkers; David McDonald; Benigno Rodriguez; Clifford V Harding; Donald D Anthony
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 6.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

7.  Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.

Authors:  Jason T Blackard; Yoichi Hiasa; Laura Smeaton; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2007-05-02       Impact factor: 5.226

8.  Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay.

Authors:  Philippe Halfon; Marc Bourlière; Denis Ouzan; Damien Sène; David Saadoun; Hacène Khiri; Guillaume Pénaranda; Agnes Martineau; Valérie Oulès; Patrice Cacoub
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

Review 9.  Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C.

Authors:  Ayssa A Self; Phyllis T Losikoff; Stephen H Gregory
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

10.  Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.

Authors:  Florian Douam; Louis-Marie Bobay; Guillemette Maurin; Judith Fresquet; Noémie Calland; Carine Maisse; Tony Durand; François-Loïc Cosset; Cyrille Féray; Dimitri Lavillette
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.